Financial implications of New York City's weight management initiative.

Journal Article (Journal Article)

Purpose

To estimate potential annual savings in medical expenditures from a subsidized weight management program from the NYC Government perspective.

Design

Longitudinal observational study.

Setting

Employees of New York City (NYC) government and enrolled dependents.

Sample

14,946 participants with overweight and obesity.

Intervention

WW (formerly Weight Watchers®) 'Workshop' and 'Digital' programs.

Measures

Participation rate, enrollment duration, weight change, and predicted gross and net total and per capita medical expenditure savings and return on investment (ROI).

Analysis

Participation rate, enrollment duration, weight change, and program costs are based on direct observation. Predicted savings are simulated based on published data relating weight loss to medical expenditure reductions.

Results

In total, 47% of participating employees and 50% of participating dependents lost weight during the enrollment period. Mean (median) enrollment duration for employees was 7.1 months (7.0) and for dependents was 6.9 months (6.0). Mean (median) weight losses for the employees in 'Workshops' and 'Digital' was 6.6 lbs (2.80) and 6.3 lbs (0.0). For dependents, weight losses were 7.4 lbs (3.59) and 11.6 lbs (2.0). Per capita and total predicted net savings to NYC Government from employees was estimated to be $120 and $1,486,102 for an ROI of 143%. Including dependents, predicted net savings increases to $1,963,431 for an ROI of 189%. Over 80% of savings came from participants in the Obese III category.

Conclusion

An evidence-based weight management program has the potential to generate a positive ROI for employers. Future studies should validate these estimates using actual data and more rigorous designs.

Full Text

Duke Authors

Cited Authors

  • Agrawal, S; Wojtanowski, AC; Tringali, L; Foster, GD; Finkelstein, EA

Published Date

  • January 2021

Published In

Volume / Issue

  • 16 / 2

Start / End Page

  • e0246621 -

PubMed ID

  • 33571249

Pubmed Central ID

  • PMC7877753

Electronic International Standard Serial Number (EISSN)

  • 1932-6203

International Standard Serial Number (ISSN)

  • 1932-6203

Digital Object Identifier (DOI)

  • 10.1371/journal.pone.0246621

Language

  • eng